Compare STAA & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STAA | OMDA |
|---|---|---|
| Founded | 1982 | 2011 |
| Country | United States | United States |
| Employees | N/A | 943 |
| Industry | Ophthalmic Goods | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 867.9M | 978.5M |
| IPO Year | 1995 | N/A |
| Metric | STAA | OMDA |
|---|---|---|
| Price | $29.84 | $17.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $22.81 | $21.73 |
| AVG Volume (30 Days) | 965.6K | ★ 1.2M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $239,442,000.00 | N/A |
| Revenue This Year | $30.82 | $24.96 |
| Revenue Next Year | $8.41 | $20.08 |
| P/E Ratio | $292.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.59 | $10.28 |
| 52 Week High | $35.87 | $26.92 |
| Indicator | STAA | OMDA |
|---|---|---|
| Relative Strength Index (RSI) | 53.77 | 70.80 |
| Support Level | $23.75 | $14.39 |
| Resistance Level | $35.87 | $19.26 |
| Average True Range (ATR) | 1.69 | 0.86 |
| MACD | -0.39 | 0.09 |
| Stochastic Oscillator | 35.16 | 84.64 |
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.